This video is entirely AI generated and does not replicate any original material. It should not be considered a substitute for authentic sources. For complete context and techniques, viewers are encouraged to refer to the original content.
Based on findings from:
-
Color Health Becomes First Virtual Cancer Clinic to Earn ASCO Certified Status for Compliance with Quality and Safety Standards
-
Artera Receives U.S. FDA Clearance for ArteraAI Breast, Expanding Its AI Platform to Breast Cancer
-
FDA Expands AI Capabilities and Completes Data Platform Consolidation
-
AI-Generated Deepfakes: Key Policy Principles and Proposed Protections
AMA Center for Digital Health & AI. 2026.
Weekly News Brief: May 11–15, 2026
To catch up on all of the news from this past week, listen to our weekly news brief for the week of May 11–15, 2026.
This week’s brief covers Color Health's virtual cancer clinic receiving ASCO Certified status, the FDA's clearance of ArteraAI's digital pathology tool for breast cancer risk stratification, the FDA's Elsa 4.0 AI upgrade, and the AMA's new policy framework against AI physician deepfakes.
To learn more about Color's Virtual Cancer Clinic, read "Virtual Cancer Clinic Is First to Receive ASCO Certified Status," or see the press release.
For more information on ArteraAI Breast, read "ArteraAI Breast Receives FDA Clearance for Risk Assessment in HR+, HER2– Breast Cancer," or see the press release.
To learn more about the FDA AI update, read "FDA Upgrades Internal AI Tool," or see the news release.
For more information on AMA policies on deepfakes, read "AMA Issues Policy to Protect Physicians From AI Deepfakes," or see the policy framework from the AMA.
Disclaimer: This newscast was generated with the assistance of AI tools and avatars. All content is reviewed and approved by the editorial staff of ASCO AI in Oncology. Contact us with any questions.
The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. The mention of any company, product, service, or therapy should not be construed as an endorsement of any kind. Conexiant and ASCO assume no responsibility for any injury or damage to persons or property arising out of or related to any use of material contained in this publication or to any errors or omissions.